Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial

Prognosis in patients with post allogeneic HCT-early relapse of acute myeloid leukemia (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2021-03, Vol.100 (3), p.817-824
Hauptverfasser:	Amit, Odelia, On, Yael Bar, Perez, Galit, Shargian-Alon, Liat, Yeshurun, Moshe, Ram, Ron
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Chemotherapy, Adjuvant Combined Modality Therapy Female Graft vs Host Disease - mortality Graft vs Host Disease - therapy Hematology Hematopoietic Stem Cell Transplantation - adverse effects Humans Leukemia Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - therapy Lymphocyte Transfusion Male Medical prognosis Medicine Medicine & Public Health Middle Aged Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - therapy Oncology Original Article Postoperative Period Recurrence Retrospective Studies Salvage Therapy - methods Stem cell transplantation Sulfonamides - therapeutic use Survival Analysis Time Factors Transplantation, Homologous - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Prognosis in patients with post allogeneic HCT-early relapse of acute myeloid leukemia (
ISSN:	0939-5555 1432-0584
DOI:	10.1007/s00277-021-04398-y